Pomegranate Menopause Symptoms Randomized Trial Evidence Table

Structured evidence table for Pomegranate Menopause Symptoms Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Pomegranate Menopause Symptoms Randomized TrialBackground/Objectives: Polycystic ovary syndrome (PCOS) is a multifactorial endocrine disorder frequently associated with metabolic and inflammatory disturbances.1Silveira V (2025)Effects of Pomegranate Juice on Androgen Levels, Inflammation and Lipid Profile in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.
Pomegranate Menopause Symptoms Randomized TrialDue to its antioxidant and anti-inflammatory properties, pomegranate juice has been proposed as a potential adjunctive therapy in managing PCOS.1Silveira V (2025)Effects of Pomegranate Juice on Androgen Levels, Inflammation and Lipid Profile in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.
Pomegranate Menopause Symptoms Randomized TrialBackground/Objectives : Interindividual variability in polyphenol metabolism may help explain the inconsistent effects of polyphenol intake on health outcomes.2Jarrín-Orozco MP (2025)Polyphenol-Related Gut Metabotype Signatures Linked to Quality of Life in Postmenopausal Women: A Randomized, Placebo-Controlled Crossover Trial.
Pomegranate Menopause Symptoms Randomized TrialThis study compared, for the first time, (i) polyphenol-related gut microbiota metabotypes (urolithins: UM0, UMA, UMB; equol: EP, ENP; lunularin: LP, LNP) and their clusters (MCs) in non-medicated premenopausal (Pre-M) and postmenopausal (Post-M) women and (ii) the impact of an 8-week intake of a polyphenol-rich plant extract mixture (PPs) on the quality of life (QoL) of Post-M.2Jarrín-Orozco MP (2025)Polyphenol-Related Gut Metabotype Signatures Linked to Quality of Life in Postmenopausal Women: A Randomized, Placebo-Controlled Crossover Trial.
topicPomegranate Menopause Symptoms Randomized Trial
claimBackground/Objectives: Polycystic ovary syndrome (PCOS) is a multifactorial endocrine disorder frequently associated with metabolic and inflammatory disturbances.
evidence level1
citationSilveira V (2025)
sourceEffects of Pomegranate Juice on Androgen Levels, Inflammation and Lipid Profile in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.
topicPomegranate Menopause Symptoms Randomized Trial
claimDue to its antioxidant and anti-inflammatory properties, pomegranate juice has been proposed as a potential adjunctive therapy in managing PCOS.
evidence level1
citationSilveira V (2025)
sourceEffects of Pomegranate Juice on Androgen Levels, Inflammation and Lipid Profile in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.
topicPomegranate Menopause Symptoms Randomized Trial
claimBackground/Objectives : Interindividual variability in polyphenol metabolism may help explain the inconsistent effects of polyphenol intake on health outcomes.
evidence level2
citationJarrín-Orozco MP (2025)
sourcePolyphenol-Related Gut Metabotype Signatures Linked to Quality of Life in Postmenopausal Women: A Randomized, Placebo-Controlled Crossover Trial.
topicPomegranate Menopause Symptoms Randomized Trial
claimThis study compared, for the first time, (i) polyphenol-related gut microbiota metabotypes (urolithins: UM0, UMA, UMB; equol: EP, ENP; lunularin: LP, LNP) and their clusters (MCs) in non-medicated premenopausal (Pre-M) and postmenopausal (Post-M) women and (ii) the impact of an 8-week intake of a polyphenol-rich plant extract mixture (PPs) on the quality of life (QoL) of Post-M.
evidence level2
citationJarrín-Orozco MP (2025)
sourcePolyphenol-Related Gut Metabotype Signatures Linked to Quality of Life in Postmenopausal Women: A Randomized, Placebo-Controlled Crossover Trial.

Source documents

  1. Effects of Pomegranate Juice on Androgen Levels, Inflammation and Lipid Profile in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.
  2. Polyphenol-Related Gut Metabotype Signatures Linked to Quality of Life in Postmenopausal Women: A Randomized, Placebo-Controlled Crossover Trial.